If HSAs and FSAs were functioning as originally intended, the rising out-of-pocket costs faced by most Americans would be met with increased financial fluency and agency. The post HSAs And FSAs Were Designed to Give Consumers Control and Clarity of Their Healthcare Spending — Why Isn’t This Happening? appeared first on MedCity News.
Through a new partnership, Marathon employer clients who don’t currently offer Lantern’s specialty care benefit can purchase it directly through Marathon. The post Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care appeared first on MedCity News.
As Marketplace Open Enrollment nears, policy changes could leave millions of people facing substantially higher premiums and coverage loss, which could lead more consumers to purchase less expensive and less comprehensive coverage through short-term health plans. KFF analyzes short-term health policies sold by nine large insurers in 36 states, examining premiums, cost sharing, covered benefits,…
EHR vendor exec discusses national survey of practices in which 62% of clinicians and practice managers reported using four or more AI-enabled tools
The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication. The post Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin…
This Peterson-KFF Health System Tracker chart collection examines trends in employee spending on deductibles, copayments, and coinsurance from 2012 to 2023 using a sample of health benefit claims for individuals under 65.
Montana lawmakers are grappling with what they can do to improve patient care and operations at the state’s psychiatric hospital since realizing that the efforts underway to restore the troubled facility’s good standing could take more time. The nearly 150-year-old Montana State Hospital has recently struggled to care for patients and retain staff. The problems…
The answer to this question depends, not only on how well AI tools work, but also on how AI technologies are regulated by the FDA. Scott Gottlieb has some thoughts on preferred regulatory approaches in his recent article in JAMA Health Forum. Artificial intelligence tools with advanced analytical capabilities used in clinical practice, especially tools…
The Business Group on Health’s new trends report warns that rising healthcare costs will be a major challenge in 2026, prompting employers to adopt innovative strategies to manage expenses. The post 8 Trends Employers Should Watch in 2026, Per Business Group on Health appeared first on MedCity News.
Arbital Health’s $31 million Series B round was led by Valtruis and included participation from existing investors Transformation Capital, Shaper Capital and Healthy Ventures. The post Arbital Health Raises $31M to Support Value-Based Care Contracting appeared first on MedCity News.